Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Short Interest Update

Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) was the recipient of a large growth in short interest in November. As of November 15th, there was short interest totalling 3,460,000 shares, a growth of 25.4% from the October 31st total of 2,760,000 shares. Based on an average trading volume of 737,900 shares, the short-interest […]

Related Keywords

Jill Desimone ,Sphera Funds Management ,Praxis Precision Medicines Inc ,Nasdaq ,Praxis Precision Medicines Company Profile ,Vr Adviser ,Praxis Precision Medicines ,Get Free Report ,Praxis Precision ,Director Jill Desimone ,Asset Management ,Capital Partners ,Funds Management ,Precision Medicines ,Praxis Precision Medicines Daily ,Nasdaq Prax ,Aprax ,Medical ,Stocks ,Options ,Put ,Call ,